International Journal of Infectious Diseases
Volume 11, Issue 2 , Pages 109-114 , March 2007

Occurrence and antimicrobial resistance pattern of inpatient and outpatient isolates of Pseudomonas aeruginosa in a Saudi Arabian hospital: 1998–2003

Received 25 July 2005 ,Revised 4 November 2005 ,Accepted 11 November 2005.

References 

  1. Carmeli Y, Troillet N, Karchmer AW, Samore MH. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med. 1999;159:1127–1132
  2. El Amari EB, Chamot E, Auckenthaler R, Pechere JC, Van Delden C. Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis. 2001;33:1859–1864
  3. Jones RN, Kirby JT, Beach ML, Biedenbach DJ, Pfaller MA. Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997–2000). Diagn Microbiol Infect Dis. 2002;43:239–243
  4. Falherty JP, Weinstein RA. Nosocomial infection caused by antibiotic-resistant organisms in the intensive-care unit. Infect Control Hosp Epidemiol. 1996;17:236–248
  5. Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002). Diagn Microbiol Infect Dis. 2004;50:59–69
  6. Jensen HG, Felix C. In vitro antibiotic susceptibilities of ocular isolates in North and South America. In Vitro Antibiotic Testing Group. Cornea. 1998;17:79–87
  7. Al-Jasser AM, Elkhizzi NA. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa. Saudi Med J. 2004;25:780–784
  8. Ferraro MJ National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility test: approved standard A6 and M7-A4. 8th ed.. Wayne, PA: National Committee for Clinical Laboratory Standards; 1998;
  9. Raveh D, Rudensky B, Huerta M, Aviv Y, Yinnon AM. Use of time-trend analysis in the design of empirical antimicrobial treatment of urinary tract infection. Eur J Clin Microbiol Infect Dis. 2003;22:158–164
  10. Raveh D, Rudensky B, Schlesinger Y, Benenson S, Yinnon AM. Susceptibility trends in bacteraemias: analyses of 7544 patient-unique bacteraemic episodes spanning 11 years (1990–2000). J Hosp Infect. 2003;55:196–203
  11. Mutnick AH, Rhomberg PR, Sader HS, Jones RN. Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999–2001). J Antimicrob Chemother. 2004;53:290–296
  12. Rhomberg PR, Jones RN, Sader HS, Fritsche TR MYSTIC Programme Study Group. Antimicrobial resistance rates and clonality results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme: report of year five (2003). Diagn Microbiol Infect Dis. 2004;49:273–281
  13. Brown PD, Izundu A. Antibiotic resistance in clinical isolates of Pseudomonas aeruginosa in Jamaica. Rev Panam Salud Publica. 2004;16:125–130
  14. Pitt TL, Sparrow M, Warner M, Stefanidou M. Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents. Thorax. 2003;58:794–796
  15. Huang SS, Labus BJ, Samuel MC, Wan DT, Reingold AL. Antibiotic resistance patterns of bacterial isolates from blood in San Francisco County, California, 1996–1999. Emerg Infect Dis. 2002;8:195–201
  16. Orrett FA. Antimicrobial susceptibility survey of Pseudomonas aeruginosa strains isolated from clinical sources. J Natl Med Assoc. 2004;96:1065–1069
  17. Elouennass M, Foissaud V, Trueba F, Doghmi K, Malfuson JV, Fagot T, et al. A 7-year survey of strains identified in blood cultures in a clinical hematology unit. Med Mal Infect. 2004;34:62–69
  18. Yaman A, Tasova Y, Kibar F, Inal AS, Saltoglu N, Buyukcelik O, et al. Investigation of the antibiotic susceptibility patterns of pathogens causing nosocomial infections. Saudi Med J. 2004;25:1403–1409
  19. Jung R, Fish DN, Obritsch MD, MacLaren R. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital. J Hosp Infect. 2004;57:105–111
  20. Blandino G, Marchese A, Ardito F, Fadda G, Fontana R, Lo Cascio GL, et al. Antimicrobial susceptibility profiles of Pseudomonas aeruginosa and Staphylococcus aureus isolated in Italy from patients with hospital-acquired infections. Int J Antimicrob Agents. 2004;24:515–518
  21. Friedland I, Gallagher G, King T, Woods GL. Antimicrobial susceptibility patterns in Pseudomonas aeruginosa: data from a multicenter Intensive Care Unit Surveillance Study (ISS) in the United States. J Chemother. 2004;16:437–441
  22. Barsic B, Tambic A, Santini M, Klinar I, Kutlesa M, Krajinovic V. Antibiotic resistance among nosocomial isolates in a Croatian intensive care unit—results of a twelve-year focal surveillance of nosocomial infections. J Chemother. 2004;16:273–281
  23. Harris A, Torres-Viera C, Venkataraman L, Degirolami P, Samore M, Carmeli Y. Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa. Clin Infect Dis. 1999;28:1128–1133
  24. Lang A, De Fina G, Meyer R, Aschbacher R, Zelger P, Paluselli P, et al. Antimicrobial use and susceptibility rates in isolates from intensive care unit and other nosocomial inpatient and outpatient areas. New Microbiol. 2001;24:47–56
  25. Shigemura K, Tanaka K, Okada H, Nakano Y, Kinoshita S, Gotoh A, et al. Pathogen occurrence and antimicrobial susceptibility of urinary tract infection cases during a 20-year period (1983–2002) at a single institution in Japan. Jpn J Infect Dis. 2005;58:303–308

PII: S1201-9712(06)00050-6

doi: 10.1016/j.ijid.2005.11.004

International Journal of Infectious Diseases
Volume 11, Issue 2 , Pages 109-114 , March 2007

Article Tools

* Image Usage & Resolution